396 related articles for article (PubMed ID: 27862639)
21. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
22. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
Vainshelboim B; Oliveira J; Fox BD; Kramer MR
Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
Ley B; Bradford WZ; Vittinghoff E; Weycker D; du Bois RM; Collard HR
Am J Respir Crit Care Med; 2016 Sep; 194(6):711-8. PubMed ID: 26938706
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
Taha N; D'Amato D; Hosein K; Ranalli T; Sergiacomi G; Zompatori M; Mura M
Respir Res; 2020 May; 21(1):119. PubMed ID: 32429952
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
28. Pulmonary Rehabilitation Outcomes after Single or Double Lung Transplantation in Patients with Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease.
Schneeberger T; Gloeckl R; Welte T; Kenn K
Respiration; 2017; 94(2):178-185. PubMed ID: 28601868
[TBL] [Abstract][Full Text] [Related]
29. Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry.
Buschulte K; Kabitz HJ; Hagmeyer L; Hammerl P; Esselmann A; Wiederhold C; Skowasch D; Stolpe C; Joest M; Veitshans S; Höffgen M; Maqhuzu P; Schwarzkopf L; Hellmann A; Pfeifer M; Behr J; Karpavicius R; Günther A; Polke M; Höger P; Somogyi V; Lederer C; Markart P; Kreuter M
Respir Res; 2024 Mar; 25(1):113. PubMed ID: 38448953
[TBL] [Abstract][Full Text] [Related]
30. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
[TBL] [Abstract][Full Text] [Related]
31. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.
Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
BMC Pulm Med; 2017 Jul; 17(1):104. PubMed ID: 28743305
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
[TBL] [Abstract][Full Text] [Related]
33. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study.
Mura M; Porretta MA; Bargagli E; Sergiacomi G; Zompatori M; Sverzellati N; Taglieri A; Mezzasalma F; Rottoli P; Saltini C; Rogliani P
Eur Respir J; 2012 Jul; 40(1):101-9. PubMed ID: 22241745
[TBL] [Abstract][Full Text] [Related]
34. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kataoka K; Ogawa T; Watanabe F; Arizono S
Eur Respir J; 2010 Nov; 36(5):1067-72. PubMed ID: 20413545
[TBL] [Abstract][Full Text] [Related]
35. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study.
Tonelli R; Cocconcelli E; Lanini B; Romagnoli I; Florini F; Castaniere I; Andrisani D; Cerri S; Luppi F; Fantini R; Marchioni A; Beghè B; Gigliotti F; Clini EM
BMC Pulm Med; 2017 Oct; 17(1):130. PubMed ID: 29017478
[TBL] [Abstract][Full Text] [Related]
37. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
40. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
